CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 19 filers reported holding CALLIDITAS THERAPEUTICS AB in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,323 | +13.1% | 26,688 | -1.9% | 0.30% | +20.2% |
| Q2 2023 | $431,053 | -35.3% | 27,214 | -2.1% | 0.25% | -40.4% |
| Q1 2023 | $666,246 | +49.0% | 27,795 | +5.6% | 0.42% | +41.0% |
| Q4 2022 | $447,253 | +2.6% | 26,309 | -8.5% | 0.30% | -3.3% |
| Q3 2022 | $436,000 | -14.7% | 28,742 | -0.1% | 0.30% | -10.8% |
| Q2 2022 | $511,000 | -7.3% | 28,763 | +0.0% | 0.34% | +14.4% |
| Q1 2022 | $551,000 | -18.4% | 28,762 | +5.5% | 0.30% | -10.5% |
| Q4 2021 | $675,000 | +12.1% | 27,267 | -2.0% | 0.33% | +7.1% |
| Q3 2021 | $602,000 | +28.6% | 27,836 | +75.2% | 0.31% | +32.2% |
| Q2 2021 | $468,000 | – | 15,890 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 550,000 | $13,200,000 | 1.69% |
| BVF INC/IL | 750,000 | $18,000,000 | 0.98% |
| Vivo Capital, LLC | 580,000 | $13,920,000 | 0.80% |
| Endurant Capital Management LP | 111,467 | $2,675,000 | 0.79% |
| Burrage Capital Management LLC | 11,034 | $265,000 | 0.21% |
| HHLR ADVISORS, LTD. | 350,000 | $8,400,000 | 0.06% |
| Point72 Asset Management, L.P. | 257,892 | $6,189,000 | 0.03% |
| TUDOR INVESTMENT CORP ET AL | 24,422 | $586,000 | 0.02% |
| Pentwater Capital Management LP | 61,084 | $1,466,000 | 0.02% |
| Orbimed Advisors | 17,696 | $425,000 | 0.01% |